For your convenience, we have created interactive editions of several investor documents and packed them into this eKit. These interactive documents are designed for comfortable reading and easy navigation.

Click here to access the investor kit.

Amgen - Recent Press Releases
01/29/15Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial HypercholesterolemiaPrinter Friendly Version
01/27/15Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple MyelomaPrinter Friendly Version
01/27/15Amgen's 2014 Revenues Increased 7 Percent To $20.1 Billion And Adjusted Earnings Per Share (EPS) Increased 14 Percent To $8.70Printer Friendly Version
01/22/15Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial ResultsPrinter Friendly Version
01/15/15Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal CancerPrinter Friendly Version
01/12/15Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic SyndromePrinter Friendly Version
01/08/15Amgen To Present At The 33rd Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
01/05/15Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell TherapiesPrinter Friendly Version
12/22/14Amgen Joins With LabCentral to Support Life-Sciences and Biotech Startups in Cambridge, MassachusettsPrinter Friendly Version
12/17/14Amgen Announces 30 Percent Increase In 2015 First Quarter DividendPrinter Friendly Version